Phase II trial of interferon gamma and monoclonal antibody 17-1A in pancreatic cancer: biologic and clinical effects (Q40756104)
scientific article published on December 1990
Language:
Current Data About Phase II trial of interferon gamma and monoclonal antibody 17-1A in pancreatic cancer: biologic and clinical effects
(P31) (Q13442814)
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

(P304) 2019-2026
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

(P407) (Q1860)

(P433) 12
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

(P478) 8
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

(P577) Saturday, December 1, 1990
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

(P921) (Q42824440)

(Q212961)
(P887)

(P1433) (Q400292)
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

(P1476) "Phase II trial of interferon gamma and monoclonal antibody 17-1A in pancreatic cancer: biologic and clinical effects" (language: en)
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

(P2093) M A Tempero
(P1545) 1
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

C Sivinski
(P1545) 2
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

Z Steplewski
(P1545) 3
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

E Harvey
(P1545) 4
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

L Klassen
(P1545) 5
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

H D Kay
(P1545) 6
(P248)
(P698) 2121912
(P813) Saturday, September 23, 2017

other details
description scientific article published on December 1990

External Links
(P356) 10.1200/JCO.1990.8.12.2019
(P698) 2121912